RAP1B and neoplasm: The Rap1B level in primary tumours was significantly increased in patients with advanced stages of this disease (III/IV) or harbouring metastasis, as compared with normal ovary tissues or early-stage tumours (I/II) (Fig. 7a), and this pattern was opposite to that of miR-708 (Fig. 1b,c).